🇩🇪 Back from Germany — and energized about what’s ahead for Bioelectrix ⚡️
Bioelectrix recently traveled to Germany as part of a delegation focused on strengthening cross-border collaboration in healthcare innovation. The visit gave us valuable first-hand insight into the German healthcare market, including opportunities for clinical collaboration, market entry pathways, and future investor dialogue.
Germany is consistently highlighted as one of the most important export markets for Nordic life science companies, and the trip confirmed why: strong clinical environments, a mature life science ecosystem, and a clear interest in innovations that can improve outcomes and efficiency in care.
What we explored
During the trip, Bioelectrix focused on three key areas:
1) Market potential and adoption pathways
We learned more about how innovation is implemented in Germany, from healthcare structures and decision-making to what drives adoption in clinical practice. We have now clarified partner that will help us stay align with the current pathways into the German market.
2) Clinical environments and collaboration opportunities
We met with leading clinical and innovation environments and explored how Bioelectrix can build partnerships with German clinics and research stakeholders. We are looking forward to the continuous dialogue and projects.
3) Investor ecosystem and future opportunities
Germany’s health and life science landscape includes strong investor interest and support structures. The visit helped us map relevant stakeholders and begin relationships that can support Bioelectrix’s next growth steps.
Frankfurt and Göttingen: a high-value program
Our journey started in Frankfurt, where we met inspiring innovation leaders and learned more about the clinical landscape. We then continued to Göttingen, diving deeper into the German life science ecosystem and connecting with organizations supporting innovation and growth.
Thank you to our hosts and partners
A big thank you to CO-AX Accelerator at Sahlgrenska Science Park, Swecare, and mediq Innovation Experts for an excellently organized and valuable program.
Looking ahead
We’re back with fresh energy and a clearer view of the opportunities ahead.
An awesome experience learning about the German market and the exciting opportunities for the future of Bioelectrix ⚡️
We look forward to continuing these conversations and exploring collaborations that can help bring Bioelectrix’s solutions to more patients.
